These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24920927)

  • 1. Clinical significance of promoter region hypermethylation of microRNA-148a in gastrointestinal cancers.
    Sun J; Song Y; Wang Z; Wang G; Gao P; Chen X; Gao Z; Xu H
    Onco Targets Ther; 2014; 7():853-63. PubMed ID: 24920927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer.
    Zhu A; Xia J; Zuo J; Jin S; Zhou H; Yao L; Huang H; Han Z
    Med Oncol; 2012 Dec; 29(4):2701-9. PubMed ID: 22167392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance.
    Chen Y; Song Y; Wang Z; Yue Z; Xu H; Xing C; Liu Z
    J Gastrointest Surg; 2010 Jul; 14(7):1170-9. PubMed ID: 20422307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis.
    Hanoun N; Delpu Y; Suriawinata AA; Bournet B; Bureau C; Selves J; Tsongalis GJ; Dufresne M; Buscail L; Cordelier P; Torrisani J
    Clin Chem; 2010 Jul; 56(7):1107-18. PubMed ID: 20431052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of miR-148a in gastric cancer.
    Xia J; Guo X; Yan J; Deng K
    J Cancer Res Clin Oncol; 2014 Sep; 140(9):1451-6. PubMed ID: 24659367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation-associated silencing of MicroRNA-335 contributes tumor cell invasion and migration by interacting with RASA1 in gastric cancer.
    Li Z; Li D; Zhang G; Xiong J; Jie Z; Cheng H; Cao Y; Jiang M; Lin L; Le Z; Tan S; Zou W; Gong B; Lin S; Yang K
    Am J Cancer Res; 2014; 4(6):648-62. PubMed ID: 25520857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-Regulation of miR-148a Promotes Metastasis by DNA Methylation and is Associated with Prognosis of Skin Cancer by Targeting TGIF2.
    Tian Y; Wei W; Li L; Yang R
    Med Sci Monit; 2015 Dec; 21():3798-805. PubMed ID: 26638007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis.
    Long XR; He Y; Huang C; Li J
    Int J Oncol; 2014 Jun; 44(6):1915-22. PubMed ID: 24714841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-148a regulates MEG3 in gastric cancer by targeting DNA methyltransferase 1.
    Yan J; Guo X; Xia J; Shan T; Gu C; Liang Z; Zhao W; Jin S
    Med Oncol; 2014 Mar; 31(3):879. PubMed ID: 24515776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered methylation at microRNA-associated CpG islands in hereditary and sporadic carcinomas: a methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)-based approach.
    Pavicic W; Perkiö E; Kaur S; Peltomäki P
    Mol Med; 2011; 17(7-8):726-35. PubMed ID: 21327300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.
    Zheng B; Liang L; Wang C; Huang S; Cao X; Zha R; Liu L; Jia D; Tian Q; Wu J; Ye Y; Wang Q; Long Z; Zhou Y; Du C; He X; Shi Y
    Clin Cancer Res; 2011 Dec; 17(24):7574-83. PubMed ID: 21994419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of CRKL by microRNA-335 methylation is associated with poor prognosis in gastric cancer.
    Zhang JK; Li YS; Zhang CD; Dai DQ
    Cancer Cell Int; 2017; 17():28. PubMed ID: 28239297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer.
    Sandhu R; Rivenbark AG; Mackler RM; Livasy CA; Coleman WB
    Int J Oncol; 2014 Feb; 44(2):563-72. PubMed ID: 24297604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation of the ADAM23 gene in colorectal cancer cell lines and cancer tissues.
    Choi JS; Kim KH; Jeon YK; Kim SH; Jang SG; Ku JL; Park JG
    Int J Cancer; 2009 Mar; 124(6):1258-62. PubMed ID: 19089928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML).
    Yan-Fang T; Jian N; Jun L; Na W; Pei-Fang X; Wen-Li Z; Dong W; Li P; Jian W; Xing F; Jian P
    BMC Med Genet; 2013 Jul; 14():74. PubMed ID: 23870168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.
    Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X
    Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
    Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
    BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation and loss of CD133 gene expression in colorectal cancers.
    Jeon YK; Kim SH; Choi SH; Kim KH; Yoo BC; Ku JL; Park JG
    World J Gastroenterol; 2010 Jul; 16(25):3153-60. PubMed ID: 20593500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer.
    Ramos EA; Camargo AA; Braun K; Slowik R; Cavalli IJ; Ribeiro EM; Pedrosa Fde O; de Souza EM; Costa FF; Klassen G
    BMC Cancer; 2010 Jan; 10():23. PubMed ID: 20109227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.